D.A. Davidson & Co’s Redhill Biopharma RDHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-11
| Closed | -$1.47K | – | 1372 |
|
|
2022
Q4 | $1.47K | Hold |
11
| – | – | ﹤0.01% | 1299 |
|
|
2022
Q3 | $5K | Sell |
11
-4
| -27% | -$1.82K | ﹤0.01% | 1265 |
|
|
2022
Q2 | $13K | Sell |
15
-2
| -12% | -$1.73K | ﹤0.01% | 1259 |
|
|
2022
Q1 | $42K | Hold |
17
| – | – | ﹤0.01% | 1271 |
|
|
2021
Q4 | $43K | Hold |
17
| – | – | ﹤0.01% | 1254 |
|
|
2021
Q3 | $77K | Sell |
17
-13
| -43% | -$58.9K | ﹤0.01% | 1190 |
|
|
2021
Q2 | $205K | Hold |
30
| – | – | ﹤0.01% | 1125 |
|
|
2021
Q1 | $218K | Hold |
30
| – | – | ﹤0.01% | 1065 |
|
|
2020
Q4 | $241K | Buy |
30
+11
| +58% | +$88.4K | ﹤0.01% | 919 |
|
|
2020
Q3 | $197K | Buy |
19
+2
| +12% | +$20.7K | ﹤0.01% | 886 |
|
|
2020
Q2 | $111K | Buy |
17
+6
| +55% | +$39.2K | ﹤0.01% | 901 |
|
|
2020
Q1 | $50K | Buy |
+11
| New | +$50K | ﹤0.01% | 961 |
|
|
2019
Q4 | – | Sell |
-25
| Closed | -$174K | – | 1055 |
|
|
2019
Q3 | $174K | Sell |
25
-1
| -4% | -$6.96K | ﹤0.01% | 933 |
|
|
2019
Q2 | $167K | Sell |
26
-5
| -16% | -$32.1K | ﹤0.01% | 918 |
|
|
2019
Q1 | $258K | Hold |
31
| – | – | ﹤0.01% | 946 |
|
|
2018
Q4 | $172K | Sell |
31
-3
| -9% | -$16.6K | ﹤0.01% | 1006 |
|
|
2018
Q3 | $296K | Hold |
34
| – | – | 0.01% | 913 |
|
|
2018
Q2 | $286K | Buy |
34
+2
| +6% | +$16.8K | 0.01% | 894 |
|
|
2018
Q1 | $162K | Sell |
32
-7
| -18% | -$35.4K | ﹤0.01% | 1026 |
|
|
2017
Q4 | $200K | Sell |
39
-5
| -11% | -$25.6K | ﹤0.01% | 1016 |
|
|
2017
Q3 | $475K | Hold |
44
| – | – | 0.01% | 693 |
|
|
2017
Q2 | $379K | Buy |
44
+4
| +10% | +$34.5K | 0.01% | 713 |
|
|
2017
Q1 | $383K | Buy |
40
+3
| +8% | +$28.7K | 0.01% | 702 |
|
|
2016
Q4 | $387K | Buy |
37
+10
| +37% | +$105K | 0.01% | 740 |
|
|
2016
Q3 | $368K | Buy |
+27
| New | +$368K | 0.01% | 732 |
|